Masked inherited primary arrhythmia syndromes in sudden cardiac death patients accompanied by coronary vasospasm
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Coronary vasospasms are one of the important causes of sudden cardiac death (SCD). Provocation of coronary vasospasms can be useful, though some results may lead to false positives, with patients potentially experiencing recurrent SCD despite appropriate medical treatments. We hypothesized that it is not coronary vasospasms but inherited primary arrhythmia syndromes (IPAS) that underlie the development of SCD. Methods: We analyzed 74 consecutive patients (3.8%) who survived out-of-hospital cardiac arrest among 1,986 patients who had angiographically proven coronary vasospasms. Electrical abnormalities were evaluated in serial follow-up electrocardiograms (ECGs) during and after the index event for a 3.9 years median follow-up. Major clinical events were defined as the composite of death and recurrent SCD events. Results: Forty five patients (60.8%) displayed electrocardiographic abnormalities suggesting IPAS: Brugada type patterns in six (8.2%), arrhythmogenic right ventricular dysplasia patterns in three (4.1%), long QT syndrome pattern in one (2.2%), and early repolarization in 38 (51.4%). Patients having major clinical events showed more frequent Brugada type patterns, early repolarization, and more diffuse multivessel coronary vasospasms. Brugada type pattern ECGs (adjusted hazard ratio [HR], 4.22; 95% confidence interval [CI], 1.16 to 15.99; p = 0.034), and early repolarization (HR, 2.97; 95% CI, 1.09 to 8.10; p = 0.034) were ultimately associated with an increased risk of mortality. Conclusions: Even though a number of aborted SCD survivors have coronary vasospasms, some also have IPAS, which has the potential to cause SCD. Therefore, meticulous evaluations and follow-ups for IPAS are required in those patients.
Abstract
Background/Aims: Coronary vasospasms are one of the important causes of sudden cardiac death (SCD). Provocation of coronary vasospasms can be useful, though some results may lead to false positives, with patients potentially experiencing recurrent SCD despite appropriate medical treatments. We hypothesized that it is not coronary vasospasms but inherited primary arrhythmia syndromes (IPAS) that underlie the development of SCD. Methods: We analyzed 74 consecutive patients (3.8%) who survived out-of-hospital cardiac arrest among 1,986 patients who had angiographically proven coronary vasospasms. Electrical abnormalities were evaluated in serial follow-up electrocardiograms (ECGs) during and after the index event for a 3.9 years median follow-up. Major clinical events were defined as the composite of death and recurrent SCD events. Results: Forty five patients (60.8%) displayed electrocardiographic abnormalities suggesting IPAS: Brugada type patterns in six (8.2%), arrhythmogenic right ventricular dysplasia patterns in three (4.1%), long QT syndrome pattern in one (2.2%), and early repolarization in 38 (51.4%). Patients having major clinical events showed more frequent Brugada type patterns, early repolarization, and more diffuse multivessel coronary vasospasms. Brugada type pattern ECGs (adjusted hazard ratio [HR], 4.22; 95% confidence interval [CI], 1.16 to 15.99; p = 0.034), and early repolarization (HR, 2.97; 95% CI, 1.09 to 8.10; p = 0.034) were ultimately associated with an increased risk of mortality. Conclusions: Even though a number of aborted SCD survivors have coronary vasospasms, some also have IPAS, which has the potential to cause SCD. Therefore, meticulous evaluations and follow-ups for IPAS are required in those patients.
참고문헌 (29)
- Tester DJ, "The role of molecular autopsy in unexplained sudden cardiac death", Curr Opin Cardiol, 21, pp.166~172 (2006)
- Myerburg RJ, "Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm", N Engl J Med, 326, pp.1451~1455 (1992)
- Moss AJ, "The long QT syndrome: a prospective international study", Circulation, 71, pp.17~21 (1985)
- Gaita F, "Short QT syndrome:a familial cause of sudden death", Circulation, 108, pp.965~970 (2003)
- Brugada J, "Right bundle-branch block and ST-segment elevation in leads V1 through V3:a marker for sudden death in patients without demonstrable structural heart disease", Circulation, 97, pp.457~460 (1998)
- Antman E, "Nifedipine therapy for coronary-artery spasm: experience in 127 patients", N Engl J Med, 302, pp.1269~1273 (1980)
- Kimura E, "Treatment of variant angina with drugs: a survey of 11 cardiology institutes in Japan", Circulation, 63, pp.844~848 (1981)
- Suzuki M, "Increased QT dispersion in patients with vasospastic angina", Circulation, 98, pp.435~440 (1998)
- Parchure N, "Increased QT dispersion in patients with Prinzmetal’s variant angina and cardiac arrest", Cardiovasc Res, 50, pp.379~385 (2001)
- Basso C, "Arrhythmogenic right ventricular cardiomyopathy", Lancet, 373, pp.1289~1300 (2009)
- Haissaguerre M, "Sudden cardiac arrest associated with early repolarization", N Engl J Med, 358, pp.2016~2023 (2008)
- Priori SG, "HRS", EHRA, Heart Rhythm, pp.2013, 10[DOI]
- McKenna WJ, "Diagnosis of arrhythmogenic right ventricular dysplasia", cardiomyopathy:Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology, 1994, pp.71, 215~218
- Tikkanen JT, "Early repolarization:electrocardiographic phenotypes associated with favorable long-term outcome", Circulation, 123, pp.2666~2673 (2011)
- Takagi Y, "Importance of dual induction tests for coronary vasospasm and ventricular fibrillation in patients surviving out-of-hospital cardiac arrest", Circ J, 73, pp.767~769 (2009)
- Sasaki T, "Two cases of Brugada syndrome associated with spontaneous clinical episodes of coronary vasospasm", Intern Med, 45, pp.77~80 (2006)
- Nishizaki M, "ST-T wave changes in a patient complicated with vasospastic angina and Brugada syndrome:differential responses to acetylcholine in right and left coronary artery", Heart Vessels, 23, pp.201~205 (2008)
- Noda T, "ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetylcholine and", or ergonovine maleate in patients with Brugada syndrome, 2002, pp.40, 1841~1847
- Ong P, "Prevalence of the type 1 Brugada electrocardiogram in Caucasian patients with suspected coronary spasm", Europace, 13, pp.1625~1631 (2011)
- Gussak I, "Early repolarization syndrome:clinical characteristics and possible cellular and ionic mechanisms", J Electrocardiol, 33, pp.299~309 (2000)
- Lellouche N, "Sudden cardiac arrest:ECG repolarization after resuscitation", J Cardiovasc Electrophysiol, 22, pp.131~136 (2011)
- Rosso R, "Distinguishing “benign” from “malignant early repolarization”: the value of the ST-segment morphology", Heart Rhythm, 9, pp.225~229 (2012)
- Takagi Y, "Clinical characteristics and long-term prognosis of vasospastic angina patients who survived out-of-hospital cardiac arrest: multicenter registry study of the Japanese Coronary Spasm Association", Circ Arrhythm Electrophysiol, 4, pp.295~302 (2011)
- Kugiyama K, "Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina", Circulation, 94, pp.266~271 (1996)
- Sueda S, "A long-acting calcium antagonist over one year did not improve BMIPP myocardial scintigraphic imagings in patients with pure coronary spastic angina", Ann Nucl Med, 21, pp.85~92 (2007)
- Jain MK, "Anti-inflammatory effects of statins:clinical evidence and basic mechanisms", Nat Rev Drug Discov, 4, pp.977~987 (2005)
- Rosenson RS, "Antiatherothrombotic properties of statins: implications for cardiovascular event reduction", JAMA, 279, pp.1643~1650 (1998)
- Xu Z, "Pravastatin attenuates left ventricular remodeling and diastolic dysfunction in angiotensin II-induced hypertensive mice", J Cardiovasc Pharmacol, 51, pp.62~70 (2008)
- Yasue H, "Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers", J Am Coll Cardiol, 51, pp.1742~1748 (2008)